期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血小板功能检测在冠心病患者中的应用 被引量：4

Applying Platelet Function Monitoring to Patients with Coronary Artery Disease
下载PDF
导出
摘要 近年来,心血管疾病的抗血小板治疗引起了广泛的关注,多名学者及多项著名临床研究提出通过检测血小板功能来预测临床治疗的效果。现对目前常见的几种血小板功能检测的方法及其临床指导意义做一概述。 The number of studies focused on patients with coronary artery disease resistance to antiplatelet therapies has increased in recent years.This article describes current methods of measuring platelet function and the clinical implication of platelet function testing.
作者 罗裕 Anutebeh Verdo Zisuh 张代富
机构地区 同济大学附属上海市东方医院心内科
出处 《心血管病学进展》 CAS 2011年第4期512-516,共5页 Advances in Cardiovascular Diseases
关键词 抵抗 血小板功能检测 心血管事件 platelet function monitoring adverse cardiac events
分类号 R446.11 [医药卫生—诊断学] R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献23

  • 1Sharma RK, Reddy HK, Singh VN, et al. Aspirin and clopidogrel hyporespons- iveness and nonresponsiveness in patients with coronary artery stenting [ J]. Vasc Health Risk Manag, 2009, 5: 965-972.
  • 2Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactiv- ity[J]. Circulation, 2003, 107(23) :2908-2913.
  • 3Hayward CP, Moffat KA, Spitzer E, et al. Results of an external proficiency testing exercise on platelet dense-granule deficiency testing by whole mount elec- tron microscopy [ J ]. Am J Clin Pathol, 2009, 131 (5) :671-675.
  • 4Favalom EJ. Internal quality control and external quality assurance of platelet function tests[ J]. Semin Thromb Hemost, 2009, 35 (2) : 139-149.
  • 5Siller-Matula JM, Panzer S, Jilma B. Reproducibility and standardised reporting of the vasodllator-stimulated phosphoprotein phosphorytation assay [j]. Platelets, 2008, 19: 551-554.
  • 6Gurbel PA, Becker RC, Mann KG, et al. Platelet function monitoring in pa- tients with coronary artery disease[J]. J Am Coil Cardiol,2007, 50(19) :1822- 1834.
  • 7Butenas S, Caw/hem KM, van't Veer C, et al. Antiplatelet agents in tissue fac- tor-induced blood coagulation[J]. Blood, 200l, 97(8) :2314-2322.
  • 8Clauser S, Cramer-Borde E. Role of platelet electron microscopy in the diagno- sis of platelet disorders[J]. Semin Thromb Hemost, 2009, 35(2) :213-223.
  • 9Dichiara J, Bliden KP, Tantry US, et al. Platelet aspirin responsiveness meas- ured by VerifyNow : correlation with multiple methods and identification of a high platelet reactivity phenotype[J]. Diabetes, 2007, 56(12) :3014-3019.
  • 10Bliden KP, Dichiara J, Tantry US, et al. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutane- ous coronary intervention : is the current antiplatelet therapy adequate [ J ] .9 J Am Coll Cardiol, 2007, 49(6) :657-666.

共引文献27

同被引文献67

  • 1柳晓娜,朱宁,魏国峰,王纪文,李忠艳.糖尿病合并急性冠状动脉综合征患者血小板表面PAC-1和CD62P表达水平[J].中国动脉硬化杂志,2015,23(2):161-164. 被引量：16
  • 2朱铁虹.甲状腺功能减退症的诊断与治疗[J].国际内分泌代谢杂志,2007,27(2):142-143. 被引量：31
  • 3孙越红,王雅杰,周景茹.血小板聚集实验条件优化的研究[J].现代检验医学杂志,2007,22(2):8-9. 被引量：7
  • 4王桂文,姚辉璐,何碧娟,彭立新,黎永青.单个血小板的拉曼光谱分析[J].光谱学与光谱分析,2007,27(7):1347-1350. 被引量：16
  • 5Sharnaa RK, Reddy HK, Sillgh VN, et al. Aspirin and clopidogrel hyporesponsiveness and nonrespensiveness in patients with coronary attery. Vase Health Risk Manag, 2009, 5:965-972.
  • 6Soft F, Mareueci R, Gori AM, et al. Clopidogrel non-responsiveness and risk of cardiovaseular morbidity:an updated meta-analysis. Thromb Haemost, 2010, 103:841-848.
  • 7Lev E, Patel R, Maresh K, et al. Aspirin and elopidogrel drug response in patients undergoing percutaneous coronary intervention. The role of dual drug resistance. J Am Coll Cardiol, 2006, 47:27-33.
  • 8Bonello L, Camoin-Jau L, Arques S, et al. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphprotein phosphorylation index decrease rate of major adverse cardiovascular eventsin patients with clopidogrel resistance : a muhicenterrandomized prospective study. J Am Coll Cardiol, 2008, 51 : 1404-1411.
  • 9BoneUo L, Camoin-Jau L, Armero S, et al. Tailored elopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis. Am J Cardiol, 2009, 103:5-10.
  • 10Lordkipanidze M, Pharand C, Schampaert E, et al. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J, 2007, 28:1702-1708.

引证文献4

二级引证文献14

心血管病学进展
2011年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部